Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.
Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Ambros Therapeutics is a clinical-stage biotechnology company.
Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
Adage Capital Management has invested in 73 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Adage Capital Management's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Biopharma. The firm invests across 14 different industry categories.
Among tracked funding rounds, Kailera Therapeutics received $600.0M in a Series B round. Adage Capital Management's total known invested capital is $10.9B.
Adage Capital Management's average investment size is $148.9M across its portfolio of 73 companies.
Recent Adage Capital Management portfolio additions include Helus Pharma, LB Pharmaceuticals, Shattuck Labs, Cabaletta Bio, Climb Bio. These companies were founded in 2020 or later.